Main buyer interest
GH and IGF-1 signaling
The blend combines two upstream pathways commonly compared in recovery and body-composition research.
COA VerifiedHormonal Peptides
Buy CJC-1295 / Ipamorelin 10mg in Canada: Research Blend
4.73 reviews
● In stock — ships next business day$65.00
Purchase option
Strength
Buy more, save more
2+ vialsSave 5%
5+ vialsSave 10%
10+ vialsSave 15%
1
Add $250.00 more to unlock free shipping
Independently lab tested — 99%+ purity
COA number printed on every vial
Ships next business day, 1–3 day delivery
Discreet packaging · Secure card payment
CJC-1295 / Ipamorelin is a two-component research blend combining a GHRH analogue with a selective growth-hormone secretagogue. The product is listed as a 10mg total lyophilized blend.
The catalog does not publish a per-component ratio or specify the molecular format of CJC-1295. Researchers requiring those details should confirm the current label and batch documentation before ordering.
Store lyophilized vials refrigerated and protected from light and moisture. Follow the product-specific storage record after reconstitution.
Orders ship from within Canada in discreet packaging. Express delivery is typically 1–3 business days after dispatch.
Standard returns are not accepted because research materials cannot be safely restocked after delivery. Contact support promptly about damaged, incorrect, or compromised items.
Reconstitution calculator
Turn the vial amount into an easy-to-read volume
Enter three known values. The calculator converts the total vial amount and water added into a concentration, then shows the liquid volume and equivalent U-100 syringe units for the quantity entered.
The calculator does not choose a quantity. It converts the quantity you enter. One milligram equals 1,000 micrograms.
Bacteriostatic water is generally the most appropriate choice for multi-use research preparation because it contains a preservative for repeated vial access.
Concentration5 mg/mL0.5 mg in each 0.1 mL
Calculated liquid volume0.2 mL20 units on a U-100 syringe
Example using the values above: 10mg with 2mL of water equals 5mg/mL. A 1mg quantity equals 0.2mL, or 20 U-100 units.
CJC-1295 / Ipamorelin buyer guide
Understanding CJC-1295 / Ipamorelin: GH-Axis Interest, Evidence and Blend Choice
CJC-1295 / Ipamorelin is usually compared by buyers interested in growth-hormone signaling, recovery, sleep, and body-composition research without buying two separate compounds. CJC-1295 acts through the GHRH pathway, while Ipamorelin is a selective growth-hormone secretagogue associated with the ghrelin receptor.
The buying advantage is convenience, but a fixed blend gives up flexibility. The listing states 10mg total material and does not publish the amount of each component, so buyers who need an exact CJC-1295 format or component ratio should verify those details before ordering.
Human evidence
CJC-1295 raises GH and IGF-1
Small controlled studies found sustained hormone changes in healthy adults using a specific long-acting CJC-1295 format.
Blend advantage
Two compounds in one vial
Convenient for a fixed combined product, with less control than separately purchased compounds.
Buyer check
Confirm format and ratio
A 10mg total label does not establish a 5mg/5mg split or whether CJC-1295 includes DAC.
Product specifications
- Research name
- CJC-1295 / Ipamorelin
- Compound class
- Two-component peptide research blend
- Research targets
- GHRH receptor and growth-hormone secretagogue receptor pathways
- Listed components
- CJC-1295 and Ipamorelin
- Available strength
- 10mg total blend
- Form
- Lyophilized powder in a vial
- Documentation
- The listing identifies independent testing and COA availability
- Dispatch country
- Canada
- Intended use
- Laboratory and in-vitro research only
CJC-1295 / Ipamorelin evidence at a glance
Evidence for the individual pathways is stronger than evidence for the exact fixed blend.
| Evidence | Material studied | What was reported | Buyer takeaway |
|---|---|---|---|
| Controlled CJC-1295 studies | Long-acting CJC-1295 with DAC in healthy adults | Sustained increases in GH and IGF-1 | Human hormone evidence, not proof of physique or recovery outcomes |
| Ipamorelin pharmacology | Receptor and animal studies | Selective growth-hormone secretagogue activity | Mechanistic support with limited clinical outcome evidence |
| Combined blend evidence | CJC-1295 plus Ipamorelin | No robust published outcome trials for this exact commercial blend | Benefits and ratio-specific effects remain uncertain |
The CJC-1295 format and component ratio can materially change interpretation. Verify both against the current product documentation.
What are CJC-1295 and Ipamorelin, and why combine them?
CJC-1295 mimics growth-hormone-releasing hormone, while Ipamorelin stimulates the growth-hormone secretagogue receptor. The buyer logic is that the two signals may complement one another upstream of growth hormone and IGF-1, which is why the pairing appears in recovery, sleep, and body-composition discussions.
Direct human evidence for this exact combined product is limited. Small CJC-1295 studies showed sustained increases in GH and IGF-1, but the studied drug-affinity-complex version cannot automatically be equated with every product called CJC-1295. Ipamorelin evidence is mainly pharmacology and preclinical work.
What buyers should expect from the evidence
The strongest demonstrated human outcome is a hormone-level change, not proven muscle gain, fat loss, sleep improvement, or injury recovery. In healthy-adult trials, the studied long-acting CJC-1295 increased mean GH and IGF-1 for days, but those studies were small and did not establish the broad wellness outcomes often promoted online.
A buyer should therefore treat recovery and body-composition claims as hypotheses downstream of GH and IGF-1 rather than guaranteed results. Changes in IGF-1 can also be clinically important, so people with diabetes, active cancer concerns, pituitary disorders, pregnancy, or medications that affect glucose or hormones need individualized medical assessment.
CJC-1295 / Ipamorelin compared with Tesamorelin
The products overlap in growth-hormone-axis research but differ in composition and target strategy.
| Product | Composition | Research pathway | Bison format |
|---|---|---|---|
| CJC-1295 / Ipamorelin | Two-component blend | GHRH plus secretagogue pathways | 10mg total |
| Tesamorelin | Single GHRH analogue | GHRH receptor pathway | 5mg, 10mg |
The blend offers two pathways and convenience. Tesamorelin offers a single identified compound with stronger condition-specific visceral-fat evidence. They are not equivalent products.
Blend versus Tesamorelin or separate compounds
Choose the blend when convenience and a fixed two-pathway product are the priority. Choose separate compounds when you need to verify the exact CJC-1295 format, control each component independently, or identify which ingredient is associated with an observed response.
Tesamorelin is a single GHRH analogue with stronger condition-specific human evidence for reducing visceral abdominal fat in people with HIV-associated lipodystrophy. CJC-1295 / Ipamorelin has the broader wellness interest, but less direct human outcome evidence for the combined product.
What does 10mg total blend mean?
The 10mg label describes total nominal peptide material across both ingredients. It does not mean 10mg of CJC-1295 plus 10mg of Ipamorelin, and it does not prove an equal 5mg/5mg split.
Choose this vial if a ready-made combined product is the goal and the current label or COA provides enough identity detail for your needs. If exact component quantities or the presence of DAC matter, confirm them before purchase or choose separately identified compounds.
How to evaluate CJC-1295 / Ipamorelin quality before buying
The listing identifies independent testing and COA availability. Before ordering, confirm that the available certificate identifies the compound or blend, batch or lot, test date, analytical method, and reported result. After delivery, compare the vial label with that exact documentation rather than relying on a generic certificate.
Identity, purity, fill quantity, sterility, and endotoxin testing answer different questions. A large purity percentage does not prove every other quality attribute, so buyers should check which tests are actually reported and avoid assuming that an unlisted result was performed.
Research-use and approval status
The Bison Peptides CJC-1295 / Ipamorelin vial is supplied as a technical laboratory research material, not an authorized prescription formulation. The page summarizes published research to help buyers understand the compound, evidence, and product format; it is not an individual treatment or dosing recommendation.
Related research pages
Primary sources and status references
- PubMed: CJC-1295 as a long-acting GHRH analogue
- PubMed: Ipamorelin pharmacological profile
- Health Canada: Warning about unauthorized peptide products
Content reviewed August 11, 2026 by the Bison Peptides editorial team.
Reviews
4.73 reviews
Convenient blend
“I liked being able to purchase CJC-1295 and Ipamorelin together instead of ordering two separate products. The vial arrived securely packaged and clearly identified. The site also made the blend contents easy to understand before ordering. Very straightforward purchase.”
10mg ·
Jordan N. · Verified buyer
Nicely packaged
“Everything about the order felt professional. The vial came protected inside the shipment and the label clearly listed what was included in the blend. Shipping updates were helpful and the package arrived in great condition. I'd have no hesitation ordering this one again.”
10mg ·
Tyler A. · Verified buyer
Good product presentation
“I was mainly looking for a Canadian source carrying this particular combination. Ordering was easy and everything arrived properly sealed. The label and packaging were better than some of the other suppliers I've tried. Overall a positive experience and I would purchase again.”
10mg ·
Eric J. · Verified buyer
Frequently asked questions
What is CJC-1295 / Ipamorelin commonly researched for?
The blend is commonly discussed for GH and IGF-1 signaling, recovery, sleep, and body-composition research. Human evidence directly demonstrates hormone changes with a specific CJC-1295 format, while broader outcome claims for the exact blend remain uncertain.
Why are CJC-1295 and Ipamorelin combined?
CJC-1295 acts through the GHRH receptor and Ipamorelin through the growth-hormone secretagogue receptor. Combining them creates one fixed product aimed at two upstream signals within the GH axis.
Does the 10mg vial contain 10mg of each peptide?
No. The label describes 10mg total blend material. It does not establish a 10mg plus 10mg combination or even an equal 5mg/5mg split.
Does this CJC-1295 contain DAC?
The product name alone does not answer that. CJC-1295 is used for materials with and without a drug-affinity-complex modification. Buyers who require one format should verify the current label and batch documentation before ordering.
Is CJC-1295 / Ipamorelin better than Tesamorelin?
They suit different comparisons. The blend offers two pathways and convenience, while Tesamorelin is a single GHRH analogue with stronger human evidence for visceral-fat reduction in HIV-associated lipodystrophy. Neither is automatically better for every goal.
Should I buy the blend or separate compounds?
Choose the blend for a convenient fixed combination. Choose separate compounds when exact component quantities, independent COAs, or the ability to evaluate each ingredient separately matter more.
What should the blend COA show?
Ideally it should identify both components, the CJC-1295 format, batch or lot, test date, analytical method, and the reported amount or ratio of each component. A total purity result does not answer every one of those questions.
